eCAPRI: a novel tool combining clinical and imaging data for post-TAVI mortality prediction

Question Can an eCAPRI using imaging biomarkers from pre-operative CT scans improve the prediction of one-year mortality in patients undergoing transcatheter aortic valve replacement? Findings The eCAPRI score, integrating automated TAC volume and additional biomarkers, outperformed CAPRI and EuroSCORE Logistic in predicting one-year mortality (AUC = 0.731, p = 0.034). Clinical relevance The eCAPRI score provides a standardized approach to mortality risk assessment in transcatheter valve procedures. By improving prediction accuracy, it supports more informed clinical decisions and personalized care planning, ultimately contributing to better outcomes for patients undergoing TAVI.